Quoin Pharmaceuticals Submits IND Application for QRX003 in Peeling Skin Syndrome

-First ever IND submission for this disease, which has no current treatment or cure-

Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.